Spectral AI (MDAI) has released an update.
The Company’s cutting-edge DeepView AI®-Burn software has just secured UKCA authorization in the UK for burn wound diagnosis, promising to bring innovation to healthcare. This milestone is expected to drive revenue growth in the latter half of 2024, as the product begins to penetrate the market. Investors may want to keep an eye on this development, as it indicates a significant step forward for the Company’s presence in medical technology.
For further insights into MDAI stock, check out TipRanks’ Stock Analysis page.